Thus, our findings confirmed that HSP90AA1 may inhibit ccRCC proliferation and metastasis by affecting CADM1 expression and the PI3K-AKT signaling pathway through the regulation of FBXO7. Here, CADM1 is linked to nonpapillary renal cell carcinoma.